Health Care/Hospital

Five Years of Purposeful Fashion: LILYSILK Renews Partnership with National Breast Cancer Foundation for 'A Bloom of Care' Campaign

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- LILYSILK, the world's leading silk brand dedicated to inspiring people to live spectacularly, announced the renewal of its partnership withNational Breast Cancer Foundation, Inc.® (NBCF) through a new campaign, "A Bloo...

2026-10-01 22:00

A Formidable Type of Childhood Cancer Gets Added to Highly Regarded Library of Treatment Recommendations

New NCCN Guidelines for Pediatric Bone Sarcoma focus on how to provide the best care possible for children and adolescents with Ewing sarcoma. PLYMOUTH MEETING, Pa., Oct. 1, 2026 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®) published the first-ever edition of NCCN Cl...

2026-10-01 21:44 1

Bambusa Therapeutics Initiates Subcutaneous Dosing of BBT001 in Atopic Dermatitis, Following Compelling Intravenous Proof-of-Concept Data

First patient dosed as Bambusa expands global development of its long-acting bispecific antibody targeting both IL-4Rα and IL-31 High-concentration subcutaneous formulation designed to combine BBT001's emerging profile of rapid, deep and durable clinical activity with convenient administration a...

2026-10-01 21:00 457

Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency

* Supporting pharmaceutical, medical device, wellness, and research organizations in obtaining standardized sleep data * Expanding the use of SOMNUM scoring technology to provide clinical analysis services tailored to each customer's research objectives * AI Technologies Supporting Global...

2026-10-01 19:00 1674

PeKa B40 Screenings Reveal Undiagnosed Conditions Among Almost Half of Participants

STR recipients and their spouses aged 40 and above urged to use their free health-screening benefit at participating clinics nationwide. CYBERJAYA, Malaysia, Oct. 1, 2026 /PRNewswire/ -- Of the 328,302 people who underwent health screening through PeKa B40 in 2025, 44.5% were found to have at le...

2026-10-01 12:22 925

Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth

SINGAPORE, Oct. 1, 2026 /PRNewswire/ -- Emerald  Clinical Trials

2026-10-01 11:00 2799

IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution

SYDNEY, Oct. 1, 2026 /PRNewswire/ -- IMG  (International Medical Group) is excited to announce the successful completion of its acquisition of World Nomads. First announced in Februar...

2026-10-01 09:08 766

Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance

AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby reducing time to market. STUART, Fla., Sept. 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform co...

2026-10-01 04:00 2601

Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations

CONSHOHOCKEN, Pa., Sept. 30, 2026 /PRNewswire/ -- Suvoda , a global clinical trial technology company, today announced a new release of important advancements since unifying the marke...

2026-09-30 22:00 1838

Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month

* Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. * The development and manufacturing activities are being conducted at Piramal's dedicated sterile injectable facility in Lexington, Kentucky. * This partnership addresse...

2026-09-30 21:54 1267

Phrontline Biopharma Doses First Patient in Global Phase I/II Trial of TJ102, an FRα × CDH6 Bispecific Dual-Payload ADC

First clinical program built on Phrontline's DLP1 branched dual-payload linker platform HANGZHOU, China and SHANGHAI, Sept. 30, 2026 /PRNewswire/ -- Phrontline Biopharma, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), today announced that the f...

2026-09-30 21:53 1288

The 94th CMEF, the World's Leading Medical Device Industry Event, Set to Open in Beijing Oct. 21-24

BEIJING, Sept. 30, 2026 /PRNewswire/ -- The 94th China International Medical Equipment Fair (CMEF) and concurrent events—including ICMD, covering medical device design and manufacturing; CRS, focusing on rehabilitation and assistive technology; CECN, dedicated to elderly care and nursing; and Hea...

2026-09-30 21:16 799

Yuyu Pharma Brings Ari's Purrfect to Amazon Accelerate 2026

Korean pharmaceutical company explores Amazon AI and seller tools to grow its U.S. feline-health brand SEOUL, South Korea, Sept. 30, 2026 /PRNewswire/ -- Robert Wonsang Yu, CEO of Yuyu Pharma (KRX: 000220), attended Amazon Accelerate 2026 in Seattle from September 22 to 24 to explore how Amazon'...

2026-09-30 21:00 741

Joint Commission International Honors Healthcare Organizations and National Health Authorities with Inaugural Global Patient Safety Awards

OAK BROOK TERRACE, Ill., Sept. 30, 2026 /PRNewswire/ -- Joint Commission International (JCI) recognized the winners of the inaugural Global Patient Safety Awards today atUNIFY 2026™: Convening for Quality

2026-09-30 21:00 693

POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization

GUANGZHOU, China, Sept. 30, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today provided an update on the continued progress in the development and commercialization of its AI...

2026-09-30 20:00 1368

Zhongchao Inc. Announces 1-for-2 Share Consolidation

SHANGHAI, Sept. 30, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-2 share consolidation o...

2026-09-30 20:00 1584

Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China

BEIJING, Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical announced that results from a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating its investigational Live Double Combined Lactobacillus Capsule for Vaginal Use for the treatmen...

2026-09-30 20:00 970

Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China

BEIJING, Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical announced that results from a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating its investigational Live Double Combined Lactobacillus Capsule for Vaginal Use for the treatmen...

2026-09-30 20:00 797

EASD 2026 | Ecnoglutide Demonstrates Favorable Safety Profile in Adolescents with Obesity

HANGZHOU, China, Sept. 30, 2026 /PRNewswire/ -- At the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD), Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind") today announced that its Phase 1b randomized, double-blind, placebo-controlled study of ecnoglutide, the worl...

2026-09-30 19:00 1343

43% Improvement in Hair Breakage Resistance. Scalp Redness Down 14%. Singapore's CellResearch Presents Breakthrough Hair Data at AMWC Japan

Two independent laboratory studies on PTT-6®, the cord lining stem cell active from Singapore's CellResearch Corporation, deliver standards-based evidence on hair fiber strength and scalp condition — as the global hair and scalp care category climbs from USD 93.6 billion to USD 150.5 billion by 2...

2026-09-30 17:46 486
12345 ... 846

Week's Top Stories